Global Blood Therapeutics, Inc.
GBTDelisted Oct 5, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001629137
Global Blood Therapeutics, Inc. was delisted on Oct 5, 2022; its insiders filed their last Form 4 on Oct 6, 2022; 247 institutions reported holding it in 13F filings for Q3 2022, worth $4.67B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Global Blood Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
GBT is no longer listed, so this page shows Q3 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 247
- +53 vs. Q2 2022
- Shares held
- 68.6M
- −2.91M (−4.1%) vs. Q2 2022
- Total value
- $4.67B
- +$2.39B (+104.5%) vs. Q2 2022
- New holders
- 114
- 54 more added
- Sold out
- 61
- 58 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $68 |
| Q1 2026 | 1 | $68 |
| Q4 2025 | 1 | $68 |
| Q3 2025 | 1 | $68 |
| Q2 2025 | 1 | $68 |
| Q1 2025 | 1 | $68 |
| Q4 2024 | 1 | $68 |
| Q3 2024 | 1 | $68 |
| Q2 2024 | 1 | $68 |
| Q1 2024 | 1 | $68 |
| Q4 2023 | 1 | $68 |
| Q3 2023 | 1 | $68 |
| Q2 2023 | 1 | $68 |
| Q1 2023 | 1 | $68 |
| Q4 2022 | 2 | $42.1K |
| Q3 2022 | 247 | $4.67B |
| Q2 2022 | 195 | $2.29B |
| Q1 2022 | 203 | $2.44B |
| Q4 2021 | 206 | $1.91B |
| Q3 2021 | 187 | $1.55B |
| Q2 2021 | 192 | $2.28B |
| Q1 2021 | 214 | $2.70B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Global Blood Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivaldi Asset Management, LLC | 349,165 | $23.8M | 1.12% | +349,165 | New |
| Satter Management Co., L.P. | 356,270 | $24.3M | 23.36% | +230,000+182.1% | Added |
| Candriam Luxembourg S.C.A. | 360,956 | $24.6M | 0.17% | −418,735−53.7% | Reduced |
| Public Sector Pension Investment Board | 371,400 | $25.3M | 0.22% | +371,400 | New |
| Twin Securities, Inc. | 376,669 | $25.7M | 12.38% | +376,669 | New |
| American Century Companies Inc | 391,051 | $26.6M | 0.02% | +13,189+3.5% | Added |
| Alliancebernstein L.P. | 399,290 | $27.2M | 0.01% | +326,790+450.7% | Added |
| Carlson Capital L P | 400,000 | $27.2M | 2.07% | +400,000 | New |
| Allianz Asset Management GmbH | 401,197 | $27.3M | 0.06% | +401,197 | New |
| Westchester Capital Management, LLC | 405,863 | $27.6M | 0.83% | +405,863 | New |
| Gabelli Funds LLC | 432,378 | $29.4M | 0.24% | +413,178+2,152.0% | Added |
| Farallon Capital Management, L.L.C. | 450,000 | $30.6M | 0.19% | +450,000 | New |
| Morgan Stanley | 464,630 | $31.6M | 0.00% | −391,669−45.7% | Reduced |
| FMR LLC | 467,573 | $31.8M | 0.00% | −2,614,144−84.8% | Reduced |
| Charles Schwab Investment Management Inc | 480,794 | $32.7M | 0.01% | +47,651+11.0% | Added |
| Millennium Management LLC | 543,632 | $37.0M | 0.05% | +159,673+41.6% | Added |
| Price T Rowe Associates Inc | 571,115 | $38.9M | 0.01% | −2,535,686−81.6% | Reduced |
| Highland Capital Management Fund Advisors, L.P. | 577,150 | $39.3M | 2.63% | +577,150 | New |
| Northern Trust Corp | 583,069 | $39.7M | 0.01% | +8,647+1.5% | Added |
| Nuveen Asset Management, LLC | 589,525 | $40.1M | 0.02% | −60,744−9.3% | Reduced |
| Assenagon Asset Management S.A. | 590,153 | $40.2M | 0.17% | +421,383+249.7% | Added |
| CNH Partners LLC | 605,777 | $41.3M | 0.91% | +605,777 | New |
| Man Group plc | 639,097 | $43.5M | 0.20% | +639,097 | New |
| Versor Investments LP | 641,904 | $43.7M | 2.60% | +641,904 | New |
| Water Island Capital LLC | 649,242 | $44.2M | 2.50% | +649,242 | New |
| Kim, LLC | 660,000 | $44.9M | 2.09% | +660,000 | New |
| TIG Advisors, LLC | 696,420 | $47.4M | 1.80% | +696,420 | New |
| Alpine Associates Management Inc. | 743,397 | $50.6M | 2.10% | +743,397 | New |
| Magnetar Financial LLC | 829,531 | $56.5M | 0.78% | +829,531 | New |
| Norges Bank | 960,504 | $65.4M | 0.02% | +387,709+67.7% | Added |
| Janus Henderson Group PLC | 1,095,343 | $74.6M | 0.06% | −3,382,905−75.5% | Reduced |
| Geode Capital Management, LLC | 1,142,444 | $77.8M | 0.01% | +58,608+5.4% | Added |
| Balyasny Asset Management LLC | 1,151,518 | $78.4M | 0.30% | +1,151,518 | New |
| Two Sigma Advisers, LP | 1,152,900 | $78.5M | 0.23% | +818,800+245.1% | Added |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80.1M | 11.28% | −269,687−18.7% | Reduced |
| Glazer Capital, LLC | 1,412,219 | $96.2M | 1.76% | +1,412,219 | New |
| Citigroup Inc | 1,586,334 | $108.0M | 0.15% | +1,397,250+739.0% | Added |
| Goldman Sachs Group Inc | 1,706,600 | $116.2M | 0.03% | +1,033,433+153.5% | Added |
| UBS Oconnor LLC | 2,238,787 | $152.5M | 1.75% | +2,238,787 | New |
| FIL Ltd | 2,263,000 | $154.1M | 0.20% | +2,263,000 | New |
| JPMorgan Chase & Co | 2,304,636 | $156.9M | 0.02% | +1,898,523+467.5% | Added |
| Perceptive Advisors LLC | 2,322,247 | $158.1M | 4.60% | −692,807−23.0% | Reduced |
| State Street Corp | 2,384,677 | $162.4M | 0.01% | −2,038,867−46.1% | Reduced |
| Pentwater Capital Management LP | 3,200,000 | $217.9M | 3.30% | +3,200,000 | New |
| Baker Bros. Advisors LP | 3,732,502 | $254.2M | 1.66% | 00.0% | Unchanged |
| BlackRock Inc. | 4,749,863 | $323.5M | 0.01% | −22,528−0.5% | Reduced |
| Vanguard Group Inc | 6,282,173 | $427.8M | 0.01% | +262,742+4.4% | Added |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −2,044,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,524,485−100.0% | Sold out |
| Yiheng Capital Management, L.P. | 0 | $0 | 0.00% | −1,501,382−100.0% | Sold out |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −1,095,810−100.0% | Sold out |
| Fairmount Funds Management LLC | 0 | $0 | 0.00% | −953,396−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −805,861−100.0% | Sold out |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −800,000−100.0% | Sold out |
| Finepoint Capital LP | 0 | $0 | 0.00% | −474,000−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −469,444−100.0% | Sold out |
| EULAV Asset Management | 0 | $0 | 0.00% | −380,000−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −288,534−100.0% | Sold out |
| Rice Hall James & Associates, LLC | 0 | $0 | 0.00% | −231,435−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −161,309−100.0% | Sold out |
| DSC Advisors, L.P. | 0 | $0 | 0.00% | −160,000−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −106,966−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −105,305−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −103,138−100.0% | Sold out |
| Prosight Management, LP | 0 | $0 | 0.00% | −101,847−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −90,463−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −85,000−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −81,007−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −74,261−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −64,808−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −61,589−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −58,663−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −50,137−100.0% | Sold out |
| Banque Pictet & Cie SA | 0 | $0 | 0.00% | −41,898−100.0% | Sold out |
| Crestline Management, LP | 0 | $0 | 0.00% | −39,726−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −26,780−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −26,472−100.0% | Sold out |
| Capital Impact Advisors, LLC | 0 | $0 | 0.00% | −24,167−100.0% | Sold out |
| Elkhorn Partners Limited Partnership | 0 | $0 | 0.00% | −18,600−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −17,773−100.0% | Sold out |
| Vestmark Advisory Solutions, Inc. | 0 | $0 | 0.00% | −17,644−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −15,906−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −14,454−100.0% | Sold out |
| Argent Trust Co | 0 | $0 | 0.00% | −12,984−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −12,764−100.0% | Sold out |
| Fiduciary Trust Co | 0 | $0 | 0.00% | −11,550−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −10,021−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −8,893−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −7,921−100.0% | Sold out |
| New York Life Investments Alternatives | 0 | $0 | 0.00% | −7,609−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −7,561−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −6,672−100.0% | Sold out |
| Wedbush Securities Inc | 0 | $0 | 0.00% | −6,472−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −6,436−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −6,383−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −3,336−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −2,110−100.0% | Sold out |
| FourThought Financial, LLC | 0 | $0 | 0.00% | −1,271−100.0% | Sold out |
| Tortoise Investment Management, LLC | 0 | $0 | 0.00% | −1,267−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −1,050−100.0% | Sold out |